Skip to main navigation
Madrigal Pharmaceuticals Madrigal Pharmaceuticals.
  • About Us
    • Overview
    • Leadership
    • Board Of Directors
  • Our Programs
    • Overview
    • Resmetirom
      • Clinical Trials
      • Publications
  • NASH
    • Overview
    • Patient and HCP Perspectives
    • Resources
  • Investors & Media
    • Overview
    • Press Releases
    • Events and Presentations
    • Financials and Filings
    • Stock Information
    • Corporate Governance
    • FAQs
  • Careers
    • Join the team
  • Contact
    • General Inquires
    • Medical Information Inquiries
    • Medical Education Grant Submissions
Search
  • About Us
    • Overview
    • Leadership
    • Board Of Directors
  • Our Programs
    • Overview
    • Resmetirom
      • Clinical Trials
      • Publications
  • NASH
    • Overview
    • Patient and HCP Perspectives
    • Resources
  • Investors & Media
    • Overview
    • Press Releases
    • Events and Presentations
    • Financials and Filings
    • Stock Information
    • Corporate Governance
    • FAQs
  • Careers
    • Join the team
  • Contact
    • General Inquires
    • Medical Information Inquiries
    • Medical Education Grant Submissions
  • Overview
  • Press Releases
  • Events and Presentations
  • Financials and Filings
  • Stock Information
  • Corporate Governance
  • FAQs
Committee Charters
Audit Committee Charter
Audit Committee Charter
Compensation Committee Charter
Compensation Committee Charter
Nominating and Governance Committee Charter
Nominating and Governance Committee Charter
Governance Documents
Corporate Code of Conduct
Corporate Code of Conduct
Compliance Documents
Policy on Security Holder Communications with Directors
Policy on Security Holder Communications with Directors

We are conducting a late-stage clinical development program to demonstrate the benefit of resmetirom to patients with NASH and liver fibrosis.

Learn More
Madrigal Pharmaceuticals. Logo

Madrigal Pharmaceuticals

200 Barr Harbor Drive,
Suite 200

West Conshohocken,
Pennsylvania 19428

  • About Us
  • Our Programs
  • NASH
  • Investors & Media
  • Careers
  • Contact
Madrigal Pharmaceuticals
  • Terms of Use
  • Privacy
  • Cookies
  • CA COMPLIANCE
©2022 Madrigal Pharmaceuticals. All rights reserved.